The increased amount of melanin leads to skin disorders such as age spots, freckles, melasma and malignant melanoma. Tyrosinase is known to be the key enzyme in melanin production. Plants and their extracts are inexpensive and rich resources of active compounds that can be utilized to inhibit tyrosinase as well as can be used for the treatment of dermatological disorders associated with melanin hyperpigmentation. Using in vitro tyrosinase inhibitory activity assay, extracts from 13 plant species from Brazilian Cerrado were evaluated. The results showed that Pouteria torta and Eugenia dysenterica extracts presented potent in vitro tyrosinase inhibition compared to positive control kojic acid. Ethanol extract of Eugenia dysenterica leaves showed significant (p<0.05) tyrosinase inhibitory activity exhibiting the IC50 value of 11.88 µg/mL, compared to kojic acid (IC50 value of 13.14 µg/mL). Pouteria torta aqueous extract leaves also showed significant inhibitory activity with IC50 value of 30.01 µg/mL. These results indicate that Pouteria torta and Eugenia dysenterica extracts and their isolated constituents are promising agents for skin-whitening or antimelanogenesis formulations.
Citation: Souza PM, Elias ST, Simeoni LA, de Paula JE, Gomes SM, Guerra ENS, et al. (2012) Plants from Brazilian Cerrado with Potent Tyrosinase Inhibitory Activity. PLoS ONE 7(11): e48589. doi:10.1371/journal.pone.0048589
Editor: Pal Bela Szecsi, Gentofte University Hospital, Denmark
Received: June 29, 2012; Accepted: October 3, 2012; Published: November 16, 2012
Copyright: © 2012 Souza et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported by Fundação de Apoio à Pesquisa do Distrito Federal (FAPDF), Fundação de Empreendimentos Científicos e Tecnológicos (FINATEC), Conselho Nacional de Pesquisa (CNPq) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). The authors are grateful to Universidade de Brasília (UnB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Tyrosinase (polyphenoloxidase, PPO, E.C. 188.8.131.52) is a copper containing enzyme that catalyzes two distinct reactions, involving molecular oxygen with various phenolic substrates: the o-hydroxylation of monophenols to o-diphenols (monooxygenase or cresolase activity) and the subsequent oxidation of o-diphenols to o-quinones (diphenolase or catecholase activity) , . In melanin biosynthesis, tyrosinase converts L-tyrosine, monophenol, firstly to L-DOPA (o-diphenol) and this to o-dopaquinone, which is spontaneously cyclated in form of leukodopachrome and quickly converted into dopachrome, which polymerizes and form melanin , , .
Melanin is one of the most widely distributed pigments and is found in bacteria, fungi, plants and animals. The color of mammalian skin and hair is determined by a number of factors, the most important of which is the degree and distribution of melanin pigmentation . Melanin plays a crucial role in the absorption of free radicals and protects skin from various types of ionizing radiations, including UV . However, the increased amount of melanin results in pigmentary skin disorders and occurs as a result of both genetic and enviromental factors , .
Various dermatological disorders, such as melasma, age spots and sites of actinic damage, arise from the accumulation of an excessive level of epidermal pigmentation . Tyrosinase inhibitors therefore can be clinically useful for the treatment of some dermatologic disorders associated with melanin hyperpigmentation and find applications in cosmetic products for whitening and depigmentation after sunburn , . Despite the extensive researches on lightening agents and hyperpigmentation, the existing agents present limitations in term of high toxicity, low stability, poor skin-penetration, and insufficient activity . Several compounds, such as the well-known tyrosinase inhibitors, hydroquinone, kojic acid, arbutin and corticosteroids, can cause adverse reactions, such as dermatitis and skin irritation, melanocyte destruction, post-inflammatory pigmentation, ochronosis, cytotoxicity and skin cancer . Therefore, many tyrosinase inhibitors that suppress melanogenesis have been actively studied with the aim of developing preparations for the treatment of hyperpigmentation , , .
Cerrado is the second biggest Brazilian biome and supports a wide variety of species. Plants from cerrado are known as source of compounds of high biotechnological interest, with applications on medical and food industries . Additionally, several plants of families found in this biome, e.g. Apocynaceae, Sapotaceae, Fabaceae, among others, have interesting biological activities, such as antimicrobial, anti-inflammatory, and antifungical –. Due to the rich plant diversity existing in cerrado, it is very encouraging to explore the potential of cerrado plants for dermatologic purposes; nonetheless, this biome has been poorly studied to evaluate the efficacy and therapeutic effects of crude extracts or isolated compounds .
The overall goal of this study is to screen the selected cerrado plants for new tyrosinase inhibitors using in vitro assays, which may offer a new effective and safe therapeutic approach in the management of dermatologic disorders associated with melanin hyperpigmentation.
Materials and Methods
Chemicals and Reagents
The following chemicals were obtained from Sigma-Aldrich: Tyrosinase from mushroom (lyophilized powder, ≥1000 unit/mg solid), L-tyrosine (≥98%) and kojic acid.
The plant material was collected from the cerrado biome in Brasília and surroundings. Botanical identification was performed by Professors José Elias de Paula and Sueli Maria Gomes. The voucher specimens were deposited at Herbarium of the University of Brasilia (UB) and Herbarium of the University of Campinas (UEC) (Table 1). All necessary permits were obtained for the described field studies.
The plant material was dried at room temperature and powdered in a knife mill. The hexane and ethanol crude extracts were obtained in the following way: plant material (40 g) was macerated at room temperature for seven days (repeated for three times), first with hexane (2 L), followed by ethanol (2 L). After filtration, the solvents were removed under reduced pressure at temperatures below 40°C. The aqueous extract from 400 g of plant material was obtained by infusion, using distillated water (3 L). After filtration, water was removed by lyophilization. To process the in vitro assays, no previous treatment was used over crude extracts.
Pouteria torta and Eugenia dysenterica aqueous extracts were analyzed using LaChrom Elite HPLC system (Hitachi, Tokyo, Japan) liquid chromatograph equipped with L2130 pump, L2200 auto-sampler; L2300 column oven was set at 25°C and a L2455 DAD detector (Hitachi, Tokyo, Japan). The detector was set at 280 nm. Separation was performed by Purospher Star reverse phase C18e column (5 µm, 150 mm×4.6 mm i.d.) in combination with an appropriate guard column (4×4; 5 µm particle size) (Merck, Germany). The mobile phase was a linear solvent gradient system consisting of phosphoric acid (1%) (A) and CH3CN (B), at a flow rate of 0.6 mL/min. Data acquisition was performed using EZChrom Elite software (version 3.3.2 SP1 (Scientific Software. Inc.). The compounds present in the extract were characterized according to their UV–Vis spectra and identified by their retention times in comparison with those of commercial standards.
Inhibition of Tyrosinase Activity
Tyrosinase inhibition assay was performed using Khatib et al. (2005) method with modifications . Sodium phosphate buffer (60 µL, 50 mM) at pH 6.5, 30 µL tyrosinase (25 U/mL) and 10 µL of the plant extract (1 mg/mL) were inserted into 96-well plates. The hexane and ethanol extracts were dissolved in DMSO (Dimethyl Sulfoxide) and the aqueous extracts were dissolved in distilled water. After 5 min of incubation at room temperature, 100 µL L-tyrosine (2 mM) were added and incubated for additional 20 min. The optical density (OD) of the samples at 475 nm (BioTek Synergy HT Multi-Mode Microplate Reader) were measured compared to control without inhibitor, demonstrating a linear color change with time during the 20 min of the experiment. Control incubations represent 100% enzyme activity and were conducted in a similar way by replacing extracts by buffer. For blank incubation, to allow for absorbance (A) produced by the extract, the enzyme solution was replaced by buffer. The inhibitory activity was determined by comparing the enzyme activity in the absence and presence of the evaluated inhibitor. Kojic acid was used as positive control.
The cell lines, one human keratinocyte cell line (HaCat), and one fibroblast cell line (L-929), were grown as monolayers in a mixture of Dulbecco’s modified Eagle medium and supplemented with 10% fetal bovine serum and 1% antibiotics (penicillin-streptomycin). Cells were maintained at 37°C and 5% of CO2. For all experiments, cells were detached with trypsin (0.25%)/EDTA (1 mM) solution. All cell culture reagents were purchased from Sigma-Aldrich (ET. Louis, MO). The cells line used are described in the ATCC (American Type Culture Collection).
The cells were seeded at the density of 5×103 cells/well in a 96-well plate and then treated with extracts at 500 µg/mL and with extracts at IC50 values. For negative control cells were treated only with the correspondent solvent used to dilution off extracts. Following 24 after extracts’ treatment, cell death was assessed by MTT assay and the absorbance was measured at 570 nm in a Beckman Counter reader. This test assesses the ability of mitochondrial enzymes off cells treated to convert tetrazolium salts (MTT) in formazan, so only viable cells have the ability to do this reduction, or cells which have not undergone sufficient to reduce its toxicity mitochondrial activity, and then the absorbance measured correspond to viable cells. For cytotoxicity assay, we have used the extracts that presented best results at tyrosinase inhibition assay. All experiments were carried out at least three independent times and were performed in triplicates.
All experiments were carried out in triplicate and data are expressed as mean ± SD (Standard Deviation). The enzyme inhibitory activity was calculated using the following formula: % Inhibition = [(C−A)/C]×100, where C represents the absorbance of the enzyme activity and contains enzyme and substrate; and A represents the absorbance of the test and contains enzyme, plant extract, and substrate. Any increase in absorbance due to the spontaneous hydrolysis of substrate or to rule out unspecific enzymatic inhibition was corrected by subtracting the rate between the samples and the blank incubation.
The half maximal inhibitory concentration (IC50) is a measure of the effectiveness of a compound in inhibiting biological or biochemical function values. In this study, the IC50 were estimated by nonlinear regression analysis. The dose-response curve was obtained by plotting the percentage inhibition versus logarithm of the extract concentration. For IC50 determination of plant extracts against tyrosinase, a dose-response curve with 12 values of concentration (1000 - 0.48 µg/mL) was employed. The Student’s t-test was applied to assess the presence of significant differences (p<0.05) between the extract and the positive control. All the statistical analyses were accomplished using the computer software GraphPad Prism Version 5.0.
To cytotoxicity assay, statistical analysis was performed on the means of the triplicates at least three independent for all experiments using GraphPad Prism Version 5.01, applying ANOVA One-way and Tukey’s multiple comparison.
Results and Discussion
Melanogenesis is a physiological process resulting in the synthesis of melanin pigments, which play a crucial protective role against skin photocarcinogenesis. Alterations in melanogenesis may be responsible for some clinical and histopathological features of dermatologic disorders associated with melanin hyperpigmentation. Tyrosinase inhibitors may be clinically used for the treatment of some skin disorders associated with melanin hyperpigmentation and are also important in cosmetics for skin whitening effects. Therefore, several chemicals from plant origin have been tested as cosmetics and pharmaceuticals to prevent overproduction of melanin in epidermal layers or as whitening agents , , .
Thirteen cerrado plant species were selected for investigation, and 33 extracts were tested for tyrosinase inhibitory activity. The results are shown in Table 2. Some plant extracts which demonstrated a significant capability to inhibit tyrosinase are described for the first time for this biological property. This study revealed that 22 from 33 extracts present a poor tyrosinase inhibitory activity (less than 65%) compared to the positive control kojic acid (81.31%). Among the screened plants, the most active extracts tyrosinase belonged to Pouteria species as well as Eugenia dysenterica and Stryphnodendron adstringens. Some species, such as Hancornia speciosa and Genipa americana, presented weak activity on tyrosinase. Kojic acid was used as a standard tyrosinase inhibitor and showed the IC50 value of 13.14 µg/mL. Figure 1 shows the IC50 values of the extracts that present high inhibition on tyrosinase activity.
Kojic acid as positive control. *p<0.05 vs Positive control. L: leaf; F: fruit; SB: stem bark; P: peel. Crude extract: (e) ethanol; (h) hexane; (a) aqueous.
The aqueous, ethanol and hexane extracts from leaves of E. dysenterica showed high inhibitory activity on tyrosinase (inhibition of 90.5%, 100% and 100%, respectively). Among these extracts, the aqueous extract was the most potent inhibitor with with IC50 values of 11.88 µg/mL, when compared to kojic acid. The ethanol and hexane extracts exhibited a moderate activity against tyrosinase, with IC50 values of 51.54 and 151.37 µg/mL, respectively, differing from Myrcia sphaerocarpa, belonging to the same family of E. dysenterica (Myrtaceae), previously reported presenting very low inhibition (2%) . In another research, flowers of Eugenia caryophyllata also showed a weak inhibitory activity (12%) . However, essential oil from E. dysenterica leaves presents linalool , that showed inhibitory activity of 50.5% on tyrosinase . Thus, for E. dysenterica this is the first report about such activity.
The genus Pouteria extracts showed more potent inhibitory activity compared to kojic acid. The extracts from P. torta, P. ramiflora and P. caimito leaves showed 79–100% inhibitory activity on tyrosinase. Aqueous extract from leaves of P. torta revealed inhibitory properties on enzyme with IC50 values of 30.01 µg/mL. A weak activity was found for the ethanol extracts from fruit peel and leaves of Pouteria torta with IC50 value of 104.34 and 258.53 µg/mL, respectively, against tyrosinase. The ethanol extract from leaves of P. ramiflora had little effect on the tyrosinase activity (IC50 value of 249.83 µg/mL) and a good inhibition was found for leaves of Pouteria caimito aqueous extract with IC50 value of 50.01 µg/mL against enzyme. No significant inhibitory activity was shown by the others extracts of genus Pouteria. Previous studies reported the ability of some Sapotaceae species to inhibit tyrosinase. Momtaz et al. (2008) reported that methanol and acetone extracts of the stem bark from Sideroxylon inerme showed significant inhibition of monophenolase activity (IC50 values of 63 µg/mL and 82 µg/mL, respectively) . Isolated compounds from other species of Sapotaceae family, Synsepalum dulcificum, showed inhibitory activity against tyrosinase . As far as we know, no tyrosinase inhibitory activity had been reported for Pouteria species, which may be a new source of inhibitors for the treatment of hyperpigmentation.
The ethanol extract of Stryphodendron adstringens (Fabaceae) bark stem also presented inhibitory activity on tyrosinase (inhibition of 95%) with IC50 value of 48.45 µg/mL. The aqueous extract from bark stem and seeds of S. adstringens previously showed strong activity on tyrosinase with 52% and 90% inhibition, respectively .
In the experimental conditions, the evaluated Apocynaceae species did not exhibit significant inhibition activity on tyrosinase. The hexane extracts from Hancornia speciosa leaves inhibited tyrosinase (79.92%) with weak effect (IC50 of 146.60 µg/mL). Also a low inhibition against tyrosinase was found for the hexane extract of Genipa americana (Rubiaceae) fruit with IC50 value of 361.23 µg/mL. One research reported that the extract of G. americana bark exhibited weak activity against tyrosinase with 23% inhibition .
The chromatography profile showed that aqueous leaf extract of Pouteria torta presents a large number of compounds (Figure 2A). It was observed nine main peaks. The peak 1 has characteristic UV/Vis spectra of gallic acid derivatives. In addition, the peaks of 2 and 3 have characteristic UV/Vis spectra of catechin derivatives, with maximum absorbance in close to 280 nm, and no absorption at 320 or 350 nm. Moreover, the peaks 4–9 have characteristic UV/Vis spectra of flavonols, with λmax between 340 and 370 nm. It was possible to identify catechin (peak 2), epicatechin (peak 3), myricitrin (peak 4), rutin (peak 7) and isoquercitrin (peak 8) by comparison of commercial standards (Figure 3).
Aqueous leaf extract of Eugenia dysenterica showed three main peaks in HPLC/DAD chromatogram (Figure 2B). The peaks 10–12 have characteristic UV/Vis of catechin derivatives, with maximum absorbance in close to 280 nm, and no absorption at 320 or 350 nm. These results corroborate with described by Arapitsas (2008) that showed the characteristic UV/Vis spectra of catechin and flavonoids.
From P. torta leaves aqueous extract was isolated myricitrin (myricetin-3-O-rhamnoside) as majority compound (forthcoming paper). Myricetin, as well myricitrin in minor degree, showed inhibitory activity over tyrosinase , . In the same way, gallic acid and catechins derivatives also are described as tyrosinase inhibitors , . The presence of these compounds can explain, at least in part the activity of aqueous extract of P. torta, as well as E. dysenterica.
The mechanism of mushroom tyrosinase inhibition by flavonols and catechins is well described on literature ,  and in some cases, are very similar to kojic acid inhibition mechanism. Some phenolic compounds, as flavonols and catechins, can present a good affinity for the enzyme. These compounds, containing 3-hydroxy-4-keto, 5-hydroxy-4-keto and/or di-hydroxyl moiety can chelate cooper at the active site of the enzyme, thus preventing dopachrome formation in a competitive way , .
Kubo and cols (2007), in an elegant experiment, proposed a mechanism to explain the oxidative degradation of quercetin catalyzed by mushroom tyrosinase . According this mechanism, quercetin is oxidized to corresponding o-quinone and subsequent isomerized to p-quinone methide form. Addition of water led to formation of protocatechuate intermediary, which is oxidized to a corresponding o-quinone .
The cytotoxic effect of aqueous extract from leaves of Eugenia dysenterica and Pouteria torta were evaluated in two cell lines, keratinocyte and fibroblast, which cells take part of skin components. Treatment with Eugenia dysenterica and Pouteria torta at IC50 value concentration (11.88 µg/mL and 30.01 µg/mL, respectively) did not result in cell death in both cell lines, in comparison to control, after 24 hours of treatment. Furthermore, these extracts induced mild proliferation in both cell lines. In the HaCat cell line, Eugenia dysenterica, at the concentration of 500 µg/mL, inducing cell toxicity, resulting in 32.1% of live cells after 24 hours of treatment (p<0.05), and Pouteria torta caused cell death, but the cytotoxic effect did not present significant differences compared to control, showing that the extracts did not present a severe cytotoxic at high level of extract’s concentration (Figure 4A). In the L-929, both extracts, at the concentration of 500 µg/mL, inducing cell toxicity, resulting in 41.9.1% and 45.3% of live cells after 24 hours of treatment (p<0.05) (Figure 4B).
Cells were treated with extracts at the concentration of 500 µg/mL and IC50 value. Results depict average of three independent experiments, each performed in triplicate. Treatment was conducted for 24 h. Control was normalized to 100%. *p<0.05 vs control. Crude extracts: EDa- Eugenia dysenterica (aqueous); PTa - Pouteria torta (aqueous).
The extracts of plants from Brazilian Cerrado were screened for potential inhibitory activity on tyrosinase. The results indicated that Pouteria torta and Eugenia dysenterica extracts present highest activity on tyrosinase than kojic acid. Cytotoxicity of E. dysenterica and P. torta extracts also were investigated and our data showed that all evaluated extracts were not cytotoxic to both HaCat and L-929 cells at IC50 value concentration. Additionally, taken together our results suggest that Eugenia dysenterica and Pouteria torta have potential to be used as topic formulation in skin without causing any cytotoxic effect. These extracts are only cytotoxic at higher concentrations that are not common using in formulations. Furthermore, we can prove that these extracts are not cytotoxic to keratinocyte and fibroblast at IC50 value concentration.
In conclusion, based on the obtained results from tyrosinase inhibitory assays, we report here for the first time that extracts of Pouteria torta and Eugenia dysenterica present potential to be used in skin-whitening or antimelanogenesis preparation for cosmetics or therapeutic purposes. The identification of active constituents responsible for the anti-melanogenesis effect and the phytochemical profiling are currently underway.
Conceived and designed the experiments: POM DS. Performed the experiments: POM PMS JEP SMG STE ENSG YMF. Analyzed the data: POM LAS PMS DS ENSG YMF ECS. Contributed reagents/materials/analysis tools: POM LAS DS ENSG ECS. Wrote the paper: PMS POM LAS DS ENSG STE YMF.
- 1. Falguera V, Ibarz JPA (2010) A kinetic model describing melanin formation by means of mushroom tyrosinase. Food Research International 43: 66–69. doi: 10.1016/j.foodres.2009.08.013
- 2. Sanchez-Ferrer A, Rodriguez-Lopez JN, Garcia-Canovas F, Garcia-Carmona F (1995) Tyrosinase: a comprehensive review of its mechanism. Biochim Biophys Acta 1247: 1–11. doi: 10.1016/0167-4838(94)00204-t
- 3. Faria RO, Moure VR, Amazonas MALA, Krieger N, Mitchell DA (2007) The Biotechnological Potential of Mushroom Tyrosinases. Food Technol Biotechnol 45: 287–294.
- 4. Lin J, Chiang H, Lin Y, Wen K (2008) Natural Products with Skin – Whitening Effects. Journal of Food and Drug Analysis 16: 1–10.
- 5. Kim YJ, Uyama H (2005) Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future. Cell Mol Life Sci 62: 1707–1723. doi: 10.1007/s00018-005-5054-y
- 6. Parvez S, Kang M, Chung HS, Bae H (2007) Naturally occurring tyrosinase inhibitors: mechanism and applications in skin health, cosmetics and agriculture industries. Phytother Res 21: 805–816. doi: 10.1002/ptr.2184
- 7. Ortonne JP, Passeron T (2005) Melanin pigmentary disorders: treatment update. Dermatol Clin 23: 209–226. doi: 10.1016/j.det.2005.01.001
- 8. Petit L, Pierard GE (2003) Skin-lightening products revisited. Int J Cosmet Sci 25: 169–181. doi: 10.1046/j.1467-2494.2003.00182.x
- 9. Khan SB, Azhar Ul H, Afza N, Malik A, Khan MT, et al. (2005) Tyrosinase-inhibitory long-chain esters from Amberboa ramosa. Chem Pharm Bull (Tokyo) 53: 86–89. doi: 10.1248/cpb.53.86
- 10. Karioti A, Protopappa A, Megoulas N, Skaltsa H (2007) Identification of tyrosinase inhibitors from Marrubium velutinum and Marrubium cylleneum. Bioorg Med Chem 15: 2708–2714. doi: 10.1016/j.bmc.2007.01.035
- 11. Momtaz S, Lall N, Basson A (2008) Inhibitory activities of mushroom tyrosine and DOPA oxidation by plant extracts. South African Journal of Botany 74: 577–582. doi: 10.1016/j.sajb.2008.02.005
- 12. Chiari ME, Vera DM, Palacios SM, Carpinella MC (2011) Tyrosinase inhibitory activity of a 6-isoprenoid-substituted flavanone isolated from Dalea elegans. Bioorg Med Chem 19: 3474–3482. doi: 10.1016/j.bmc.2011.04.025
- 13. Lin JY, Fisher DE (2007) Melanocyte biology and skin pigmentation. Nature 445: 843–850. doi: 10.1038/nature05660
- 14. Caramori SS, Lima SC, Fernandes KF (2004) Biochemical characterization of selected plant species from Brazilian Savannas. Braz Arch Biol Techn 47: 253–259. doi: 10.1590/s1516-89132004000200013
- 15. Boonclarm D, Sornwatana T, Arthan D, Kongsaeree P, Svasti J (2006) Beta-Glucosidase catalyzing specific hydrolysis of an iridoid beta-glucoside from Plumeria obtusa. Acta Bioch Bioph Sin 38: 563–570.
- 16. Rebecca MA, Ishii-Iwamoto EL, Grespan R, Cuman RKN, Caparroz-Assef SM, et al. (2002) Toxicological studies on Stryphnodendron adstringens. J Ethnopharmacol 83: 101–104. doi: 10.1016/s0378-8741(02)00219-2
- 17. Silva CAM, Simeoni LA, Silveira D (2009) Genus Pouteria: Chemistry and biological activity. Braz J Pharmacogn 19: 501–509. doi: 10.1590/s0102-695x2009000300025
- 18. Napolitano DR, Mineo JR, de Souza MA, de Paula JE, Espindola LS, et al. (2005) Down-modulation of nitric oxide production in murine macrophages treated with crude plant extracts from the Brazilian Cerrado. J Ethnopharmacol 99: 37–41. doi: 10.1016/j.jep.2005.01.059
- 19. Khatib S, Nerya O, Musa R, Shmuel M, Tamir S, et al. (2005) Chalcones as potent tyrosinase inhibitors: the importance of a 2,4-substituted resorcinol moiety. Bioorg Med Chem 13: 433–441. doi: 10.1016/j.bmc.2004.10.010
- 20. Baurin N, Arnoult E, Scior T, Do QT, Bernard P (2002) Preliminary screening of some tropical plants for anti-tyrosinase activity. J Ethnopharmacol 82: 155–158. doi: 10.1016/s0378-8741(02)00174-5
- 21. Lee KT, Kim BJ, Kim JH, Heo MY, Kim HP (1997) Biological screening of 100 plant extracts for cosmetic use (I): inhibitory activities of tyrosinase and DOPA auto-oxidation. Int J Cosmet Sci 19: 291–298. doi: 10.1046/j.1467-2494.1997.171725.x
- 22. Costa TR, Fernandes OF, Santos SC, Oliveira CM, Liao LM, et al. (2000) Antifungal activity of volatile constituents of Eugenia dysenterica leaf oil. J Ethnopharmacol 72: 111–117. doi: 10.1016/s0378-8741(00)00214-2
- 23. Nakatsu T, Lupo AT, Chinn JW, Kang RKL (2000) Biological activity of essential oils and their constituents. Studies in Natural Products Chemistry 21: 571–631. doi: 10.1016/s1572-5995(00)80014-9
- 24. Momtaz S, Mapunya BM, Houghton PJ, Edgerly C, Hussein A, et al. (2008) Tyrosinase inhibition by extracts and constituents of Sideroxylon inerme L. stem bark, used in South Africa for skin lightening. J Ethnopharmacol 119: 507–512. doi: 10.1016/j.jep.2008.06.006
- 25. Wang H, Chou Y, Hong Z, Chen H, Chang Y, et al.. (2010) Bioconstituents from stems of Synsepalum dulcificum Daniell (Sapotaceae) inhibit human melanoma proliferation, reduce mushroom tyrosinase activity and have antioxidant properties. Journal of theTaiwan Institute of Chemical Engineers.
- 26. Kim D, Park J, Kim J, Han C, Yoon J, et al. (2006) Flavonoids as mushroom tyrosinase inhibitors: a fluorescence quenching study. Journal of agricultural and food chemistry 54: 935–941. doi: 10.1021/jf0521855
- 27. Matsuda H, Higashino M, Chen W, Tosa H, Iinuma M, et al. (1995) Studies of cuticle drugs from natural sources. III: Inhibitory effect of Myrica rubra on melanin biosynthesis. Biological & pharmaceutical bulletin 18: 1148–1150. doi: 10.1248/bpb.18.1148
- 28. No JK, Soung DY, Kim YJ, Shim KH, Jun YS, et al. (1999) Inhibition of tyrosinase by green tea components. Life sciences 65: PL241–PL246. doi: 10.1016/s0024-3205(99)00492-0
- 29. Kim YJ, Chung JE, Kurisawa M, Uyama H, Kobayashi S (2004) New tyrosinase inhibitors, (+)-catechin-aldehyde polycondensates. Biomacromolecules 5: 474–479. doi: 10.1021/bm034320x
- 30. Oh S, Wang ZJ, Ye S (2012) An Integrated Study of Tyrosinase Inhibition by Rutin: Progress using a Computational Simulation. Journal of Biomolecular Structure & Dynamics 29: 999–1012. doi: 10.1080/073911012010525028
- 31. Chang TS (2009) An updated review of tyrosinase inhibitors. International journal of molecular sciences 10: 2440–2475. doi: 10.3390/ijms10062440
- 32. Kubo I, Kinst-Hori I (1999) Flavonols from saffron flower: tyrosinase inhibitory activity and inhibition mechanism. Journal of agricultural and food chemistry 47: 4121–4125. doi: 10.1021/jf990201q
- 33. Kubo I, Nitoda T, Nihei K (2007) Effects of quercetin on mushroom tyrosinase and B16–F10 melanoma cells. Molecules 12: 1045–1056. doi: 10.3390/12051045